Abcam PLC (ABCM)
| Market Cap | 5.21B |
| Revenue (ttm) | 329.11M |
| Net Income (ttm) | 15.82M |
| Shares Out | 225.12M |
| EPS (ttm) | 0.06 |
| PE Ratio | 430.25 |
| Forward PE | 86.96 |
| Dividend | $0.15 |
| Dividend Yield | 0.63% |
| Trading Day | January 25 |
| Last Price | $23.89 |
| Previous Close | $23.59 |
| Change ($) | 0.30 |
| Change (%) | 1.27% |
| Day's Open | 23.56 |
| Day's Range | 23.19 - 23.90 |
| Day's Volume | 240,828 |
| 52-Week Range | 18.20 - 23.90 |
News
Abcam has a strong position in the niche of supplies for antibody research. It is profitable, dividend paying, and continues to grow well.
CAMBRIDGE, United Kingdom, Nov. 03, 2020 (GLOBE NEWSWIRE) -- Abcam plc (AIM: ABC) (Nasdaq: ABCM), a global leader in the supply of life science research tools, announces that, following releas...
CAMBRIDGE, United Kingdom, Nov. 03, 2020 (GLOBE NEWSWIRE) -- Abcam plc (AIM: ABC) (Nasdaq: ABCM), a global leader in the supply of life science research tools, announces that, following consul...
About ABCM
Abcam plc, a life sciences company, researches, develops, and distributes biological reagents and tools for research, drug discovery, and diagnostics in the United States, China, Japan, Europe, the Middle East, Africa, and rest of Asia Pacific. The company offers various research products, including primary and secondary antibodies; ELISA and matched antibody pairs; cell and tissue imaging tools; cellular and biochemical assays; proteins and peptides; proteomics tools; agonists, antagonists, activators, and inhibitors; lysates; and multiplex as... [Read more...]
| Industry Biotechnology | IPO Date Oct 22, 2020 |
| CEO Murray Hennessy | Employees 1,492 |
| Stock Exchange NASDAQ | Ticker Symbol ABCM |
Financial Performance
In 2020, Abcam PLC's revenue was 260.00 million, an increase of 0.04% compared to the previous year's 259.90 million. Earnings were 12.50 million, a decrease of -72.22%.
Analyst Forecasts
According to 2 analysts, the average rating for Abcam PLC stock is "Buy." The 12-month stock price forecast is 1,562.54, which is an increase of 6,440.56% from the latest price.